Reliance Global Group reported a FY 2025 net loss of USD 7 million, improving 23%, and said the change was mainly driven by a gain on business sales and the absence of prior-year asset impairment charges. Commission income was USD 12.4 million, down 12%, reflecting portfolio realignment and divestitures including Fortman Insurance Services, Employee Benefits Solutions and U.S. Benefits Alliance. Salaries and wages rose 43% to USD 10.3 million, primarily due to non-cash share-based compensation. General and administrative expenses increased 16% to USD 4.9 million, driven by non-cash equity awards and partly offset by efficiencies tied to its OneFirm initiative. The company said it launched EZRA International Group and its Scale51 platform, completed a first investment in post-quantum cybersecurity firm Enquantum, and signed a non-binding term sheet to acquire a majority stake in AI diagnostics company Scentech Medical.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reliance Global Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603101605PRIMZONEFULLFEED9669491) on March 10, 2026, and is solely responsible for the information contained therein.
Comments